ATE469912T1 - Gegenionenaustauschverfahren für peptide - Google Patents

Gegenionenaustauschverfahren für peptide

Info

Publication number
ATE469912T1
ATE469912T1 AT05811089T AT05811089T ATE469912T1 AT E469912 T1 ATE469912 T1 AT E469912T1 AT 05811089 T AT05811089 T AT 05811089T AT 05811089 T AT05811089 T AT 05811089T AT E469912 T1 ATE469912 T1 AT E469912T1
Authority
AT
Austria
Prior art keywords
peptides
exchange process
peptide
column
counterion exchange
Prior art date
Application number
AT05811089T
Other languages
English (en)
Inventor
Avi Tovi
Chaim Eidelman
Shimon Shushan
Shai Elster
Hagi Alon
Alexander Ivchenko
Gabriel-Marcus Butilca
Gil Zaoui
Original Assignee
Novetide Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novetide Ltd filed Critical Novetide Ltd
Application granted granted Critical
Publication of ATE469912T1 publication Critical patent/ATE469912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05811089T 2004-10-04 2005-10-04 Gegenionenaustauschverfahren für peptide ATE469912T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61601004P 2004-10-04 2004-10-04
US63052804P 2004-11-22 2004-11-22
PCT/US2005/035868 WO2006041945A2 (en) 2004-10-04 2005-10-04 A counterion exchange process for peptides

Publications (1)

Publication Number Publication Date
ATE469912T1 true ATE469912T1 (de) 2010-06-15

Family

ID=36096369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05811089T ATE469912T1 (de) 2004-10-04 2005-10-04 Gegenionenaustauschverfahren für peptide

Country Status (10)

Country Link
US (1) US20060148699A1 (de)
EP (2) EP1709065B1 (de)
JP (1) JP2007513192A (de)
AT (1) ATE469912T1 (de)
CA (1) CA2582083A1 (de)
DE (1) DE602005021614D1 (de)
DK (1) DK1709065T3 (de)
ES (1) ES2344657T3 (de)
IL (1) IL182157A0 (de)
WO (1) WO2006041945A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2000126C2 (nl) * 2005-07-15 2008-01-29 Solvay Werkwijze voor de vervaardiging van eptifibatide.
US20080287650A1 (en) * 2007-03-01 2008-11-20 Avi Tovi High purity peptides
EP2181118A1 (de) * 2007-06-29 2010-05-05 Lonza Ag Verfahren zur herstellung von pramlintid
EP2062909A1 (de) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Herstellung von Peptiden und Reinigungsverfahren
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
US20100317827A1 (en) * 2008-02-06 2010-12-16 Biocon Limited Method of Purifying a Peptide
CN101314613B (zh) * 2008-05-08 2012-04-25 吉尔生化（上海）有限公司 一种阿托西班的固相合成方法
WO2009150657A1 (en) * 2008-06-09 2009-12-17 Natco Pharma Limited Improved process for preparation of eptifibatide by fmoc solid phase synthesis
CN101463080B (zh) * 2009-01-09 2011-09-14 深圳翰宇药业股份有限公司 一种纯化奈西利肽的方法
CN101696236B (zh) * 2009-02-11 2012-02-15 海南中和药业有限公司 一种固相合成阿托西班方法
US20120094910A1 (en) 2009-04-06 2012-04-19 Ananda Kuppanna Improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
WO2011011342A1 (en) * 2009-07-20 2011-01-27 Mallinckrodt Inc. Synthesis of desmopressin
MX346473B (es) * 2009-08-11 2017-03-22 Biocon Ltd Procesos cromatograficos y compuestos purificados de los mismos.
CN101787071B (zh) * 2010-02-26 2012-11-07 深圳翰宇药业股份有限公司 一种伐普肽的纯化方法
CN101780267A (zh) * 2010-03-12 2010-07-21 深圳翰宇药业股份有限公司 一种抗血小板凝集的制剂及其制备方法
CN102146121A (zh) * 2010-11-19 2011-08-10 深圳市健元医药科技有限公司 一种含有oxt拮抗剂药物的生产工艺
RU2494105C2 (ru) * 2010-12-29 2013-09-27 Общество с ограниченной ответственностью "Химфармресурс" Способ получения циклического пептида
US9388212B2 (en) 2013-02-21 2016-07-12 Chemical & Biopharmaceutical Laboratories Of Patras S.A. Solid phase peptide synthesis via side chain attachment
CN102875663B (zh) * 2012-09-26 2014-06-11 深圳翰宇药业股份有限公司 利西拉来的纯化方法
JP6382488B2 (ja) * 2013-02-21 2018-08-29 ケミカル アンド バイオファーマシューティカル ラボラトリーズ オブ パトラ エス．エー． 側鎖結合を介する固相ペプチド合成
CN103965291B (zh) * 2014-05-27 2016-09-21 上海第一生化药业有限公司 奥曲肽、奥曲肽醋酸盐的制备方法
CN106699847B (zh) * 2017-01-04 2020-08-14 陕西慧康生物科技有限责任公司 一种低成本纯化六胜肽的方法
JP6707576B2 (ja) * 2018-04-03 2020-06-10 ケミカル アンド バイオファーマシューティカル ラボラトリーズ オブ パトラ エス．エー． 側鎖結合を介する固相ペプチド合成
JP7423070B2 (ja) 2018-04-06 2024-01-29 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 増加した溶解度および改善された薬物動態特性を有するコンプスタチンアナログ
WO2020170185A1 (en) * 2019-02-21 2020-08-27 Dr. Reddy’S Laboratories Limited Substantially pure lanreotide or its salt & process thereof
CN109942686B (zh) * 2019-05-06 2021-06-25 上海上药第一生化药业有限公司 一种加压素乙酰化杂质的精制方法
CN109929011B (zh) * 2019-05-06 2021-04-06 上海上药第一生化药业有限公司 一种加压素[5-Asp]杂质的精制方法
US20220031800A1 (en) * 2019-07-26 2022-02-03 Allegro Pharmaceuticals, LLC Peptides for treating non-exudative macular degeneration and other disorders of the eye

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
GB8813160D0 (en) * 1988-06-03 1988-07-06 Soc D Etudes Prod Chimique Therapeutic methods
WO1995001368A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
EP0763061B1 (de) * 1994-06-02 2002-10-30 Forssmann, Wolf-Georg, Prof. Dr. med. Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
US5889146A (en) * 1997-11-26 1999-03-30 Institute Of Nuclear Energy Research Method for synthesis of bifunctional chelating agents-peptides
EP2305815B1 (de) * 1998-07-10 2014-11-05 Scios, Inc. Verfahren zur Herstellung eines natriuretischen Peptids mit einem pI grösser als 8 oder kleiner als 5
KR100808149B1 (ko) * 2000-02-22 2008-02-29 라보라토리스 세로노 에스.에이. 정제된 ｌｈ
ME00296B (me) * 2000-02-22 2011-05-10 Applied Res Systems Ars Holding N V PROCES PREČIŠĆAVANJA hCG I REKOMBINANTNOG hCG PREČIŠĆENOG TOM METODOM
ATE334998T1 (de) * 2003-04-07 2006-08-15 Novetide Ltd Verfahren zur herstellung cyclischer peptide
SI2204383T1 (sl) * 2004-04-08 2011-11-30 Millennium Pharm Inc Postopek za pripravo eptifibatida in dotičnih vmesnih spojin

Also Published As

Publication number Publication date
EP2163558A2 (de) 2010-03-17
DE602005021614D1 (de) 2010-07-15
ES2344657T3 (es) 2010-09-02
EP1709065A2 (de) 2006-10-11
IL182157A0 (en) 2007-07-24
JP2007513192A (ja) 2007-05-24
CA2582083A1 (en) 2006-04-20
EP1709065B1 (de) 2010-06-02
EP2163558A3 (de) 2010-10-27
WO2006041945A3 (en) 2006-08-24
US20060148699A1 (en) 2006-07-06
DK1709065T3 (da) 2010-08-23
WO2006041945A2 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
ATE469912T1 (de) Gegenionenaustauschverfahren für peptide
CY1113684T1 (el) Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη
DK1509212T3 (da) Hidtil ukendte chromium-(III)-a-aminosyrekomplekser
AR055179A1 (es) Procedimiento para la amidacion de polipeptidos con aminoacidos de caracter basico c-terminales mediante el uso de endoproteasas especificas
DE60126997D1 (de) Stickstoff-enthaltende aromatische ringverbindungen zur behandlung von tumorerkrankungen
DE60311272D1 (de) Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten
WO2006087550A3 (en) Amyloid-binding peptides, analogues and uses thereof
DE60040912D1 (de) Ein verfahren zum entschützen markierter oligonukleotide
NO20025064L (no) RGO koblet til peptider
DE602004016006D1 (de) Screening-verfahren
RU2001113277A (ru) Регуляторные/развернутые пептиды эзрина
ATE435650T1 (de) 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen
ATE338126T1 (de) Dna-sequenz und rekombinante herstellung eines graminaen-allergens
DK1660466T3 (da) Fremgangsmåde til fremstilling af urethanbeskyttede alfa-aminosyre-N-carboxyanhydrider
Jastrzabek et al. Bis (4, 6‐dimethoxy‐1, 3, 5‐triazin‐2‐yl) Ether as Coupling Reagent for Peptide Synthesis
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
DE602004022857D1 (de) 2-methyl-6-solanylbenzochinon-methyltransferase als ziel für herbizide
ATE445159T1 (de) Neues screening-verfahren
WO2007026171A8 (en) Vdcc gamma-8 ion channel
WO2003010196A3 (en) Variants and exons of the glyt1 transporter
DE60128570D1 (de) Neuartige proteine und deren dna
TH79797B (th) กระบวนการผลิตสารอินทรีย์
DE60334078D1 (de) Organische anionentransporter-proteine (oatp/lst) und ihre dna
RU2003131626A (ru) Пептид, обладающий способностью ингибировать миграцию моноцитарных клеток, стимулированную белком мср-1
JP2002335964A5 (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1709065

Country of ref document: EP